Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
AUTOR(ES)
Alvarez, J S
RESUMO
The in vitro susceptibilities of 242 isolates of Serratia marcescens to 17 antibacterial drugs have been determined. Oxolinic acid, nalidixic acid, cefoxitin, and amikacin were the most active drugs. Ampicillin, kanamycin, and cephalothin were among the least active. A 4-year study showed that resistance of S. marcescens to dibekacin, tobramycin, sisomycin, and gentamicin has increased at least one order of magnitude in that period, whereas resistance to amikacin showed but a twofold increase.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352893Documentos Relacionados
- Quinolone resistance in clinical isolates of Serratia marcescens.
- Immunophysical characterization of human isolates of Serratia marcescens.
- Nalidixic Acid Susceptibility Testing of Clinical Isolates of Serratia marcescens
- Enzyme polymorphism, prodigiosin production, and plasmid fingerprints in clinical and naturally occurring isolates of Serratia marcescens.
- Detection of pigment precursors in white clinical strains of Serratia marcescens.
